Genetically engineered cells for therapeutic applications

Details for Australian Patent Application No. 2005248352 (hide)

Owner The Cleveland Clinic Foundation

Inventors Penn, Marc S.; Kiedrowski, Matthew

Agent Fisher Adams Kelly

Pub. Number AU-B-2005248352

PCT Pub. Number WO2005/116192

Priority 60/572,349 19.05.04 US

Filing date 17 May 2005

Wipo publication date 8 December 2005

Acceptance publication date 30 July 2009

International Classifications

A61K 35/12 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Materials from mammals or birds

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C12N 5/06 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

C12N 5/08 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

Event Publications

14 December 2006 Amendment Made

  The nature of the amendment is: Add co-inventor Kiedrowski, Matthew

4 January 2007 PCT application entered the National Phase

  PCT publication WO2005/116192 Priority application(s): WO2005/116192

30 July 2009 Application Accepted

  Published as AU-B-2005248352

26 November 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005248361-Influenza virus vaccine composition and methods of use

2005248351-Methods for treating cancer using antiWnt2 monoclonal antibodies and siRNA